Filana Therapeutics, Inc. (FLNA)
NASDAQ · Healthcare
Filana Therapeutics, Inc. Shareholder Equity 2009–2013
Filana Therapeutics, Inc. annual shareholder equity history from 2010 to 2013. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Filana Therapeutics, Inc. shareholder equity as of December 31, 2013: 48.3M, a 267.71% increase year-over-year.
- Filana Therapeutics, Inc. shareholder equity for 2013 were 48.3M, a 267.71% increase from 2012.
- Filana Therapeutics, Inc. shareholder equity for 2012 were 13.1M, a 70.41% decrease from 2011.
- Filana Therapeutics, Inc. shareholder equity for 2011 were 44.4M, a 34.80% increase from 2010.
- Filana Therapeutics, Inc. shareholder equity for 2010 were 32.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Filana Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2013 | $48 |
| 2012 | $13 |
| 2011 | $44 |
| 2010 | $33 |
Filana Therapeutics, Inc. Shareholder Equity — FAQ
Filana Therapeutics, Inc. (FLNA) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLNA's shareholder equity history?
The chart and table above show Filana Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.